VILI_HUMAN - dbPTM
VILI_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID VILI_HUMAN
UniProt AC P09327
Protein Name Villin-1
Gene Name VIL1
Organism Homo sapiens (Human).
Sequence Length 827
Subcellular Localization Cytoplasm, cytoskeleton. Cell projection, lamellipodium. Cell projection, ruffle. Cell projection, microvillus. Cell projection, filopodium tip. Cell projection, filopodium. Relocalized in the tip of cellular protrusions and filipodial extensions upo
Protein Description Epithelial cell-specific Ca(2+)-regulated actin-modifying protein that modulates the reorganization of microvillar actin filaments. Plays a role in the actin nucleation, actin filament bundle assembly, actin filament capping and severing. Binds phosphatidylinositol 4,5-bisphosphate (PIP2) and lysophosphatidic acid (LPA); binds LPA with higher affinity than PIP2. Binding to LPA increases its phosphorylation by SRC and inhibits all actin-modifying activities. Binding to PIP2 inhibits actin-capping and -severing activities but enhances actin-bundling activity. Regulates the intestinal epithelial cell morphology, cell invasion, cell migration and apoptosis. Protects against apoptosis induced by dextran sodium sulfate (DSS) in the gastrointestinal epithelium. Appears to regulate cell death by maintaining mitochondrial integrity. Enhances hepatocyte growth factor (HGF)-induced epithelial cell motility, chemotaxis and wound repair. Upon S.flexneri cell infection, its actin-severing activity enhances actin-based motility of the bacteria and plays a role during the dissemination..
Protein Sequence MTKLSAQVKGSLNITTPGLQIWRIEAMQMVPVPSSTFGSFFDGDCYIILAIHKTASSLSYDIHYWIGQDSSLDEQGAAAIYTTQMDDFLKGRAVQHREVQGNESEAFRGYFKQGLVIRKGGVASGMKHVETNSYDVQRLLHVKGKRNVVAGEVEMSWKSFNRGDVFLLDLGKLIIQWNGPESTRMERLRGMTLAKEIRDQERGGRTYVGVVDGENELASPKLMEVMNHVLGKRRELKAAVPDTVVEPALKAALKLYHVSDSEGNLVVREVATRPLTQDLLSHEDCYILDQGGLKIYVWKGKKANEQEKKGAMSHALNFIKAKQYPPSTQVEVQNDGAESAVFQQLFQKWTASNRTSGLGKTHTVGSVAKVEQVKFDATSMHVKPQVAAQQKMVDDGSGEVQVWRIENLELVPVDSKWLGHFYGGDCYLLLYTYLIGEKQHYLLYVWQGSQASQDEITASAYQAVILDQKYNGEPVQIRVPMGKEPPHLMSIFKGRMVVYQGGTSRTNNLETGPSTRLFQVQGTGANNTKAFEVPARANFLNSNDVFVLKTQSCCYLWCGKGCSGDEREMAKMVADTISRTEKQVVVEGQEPANFWMALGGKAPYANTKRLQEENLVITPRLFECSNKTGRFLATEIPDFNQDDLEEDDVFLLDVWDQVFFWIGKHANEEEKKAAATTAQEYLKTHPSGRDPETPIIVVKQGHEPPTFTGWFLAWDPFKWSNTKSYEDLKAELGNSRDWSQITAEVTSPKVDVFNANSNLSSGPLPIFPLEQLVNKPVEELPEGVDPSRKEEHLSIEDFTQAFGMTPAAFSALPRWKQQNLKKEKGLF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MTKLSAQVK
------CCCCCCEEE
40.47-
5Phosphorylation---MTKLSAQVKGSL
---CCCCCCEEECCE
20.43-
11PhosphorylationLSAQVKGSLNITTPG
CCCEEECCEECCCCC
16.7228857561
15PhosphorylationVKGSLNITTPGLQIW
EECCEECCCCCEEEE
26.35-
46PhosphorylationSFFDGDCYIILAIHK
HCCCCCEEEEEEEEH
8.8516921170
60PhosphorylationKTASSLSYDIHYWIG
HHHCCCCEEEEEECC
24.9812269817
64PhosphorylationSLSYDIHYWIGQDSS
CCCEEEEEECCCCCC
10.0812269817
81PhosphorylationEQGAAAIYTTQMDDF
HHCCEEEEEECHHHH
10.0612269817
104PhosphorylationREVQGNESEAFRGYF
EECCCCCCHHHHHHC
37.9226437602
119AcetylationKQGLVIRKGGVASGM
CCCEEEEECCHHCCC
49.2230593351
124PhosphorylationIRKGGVASGMKHVET
EEECCHHCCCEEEEC
36.69-
131PhosphorylationSGMKHVETNSYDVQR
CCCEEEECCCCCHHH
28.5123312004
133PhosphorylationMKHVETNSYDVQRLL
CEEEECCCCCHHHHH
30.0823312004
134PhosphorylationKHVETNSYDVQRLLH
EEEECCCCCHHHHHE
23.3923312004
156PhosphorylationVAGEVEMSWKSFNRG
EEEEEEECCCCCCCC
20.1828258704
192PhosphorylationMERLRGMTLAKEIRD
HHHHHCCCHHHHHHH
26.7924719451
206PhosphorylationDQERGGRTYVGVVDG
HHHCCCEEEEEEECC
26.32-
207PhosphorylationQERGGRTYVGVVDGE
HHCCCEEEEEEECCC
8.2120736484
219PhosphorylationDGENELASPKLMEVM
CCCCCCCCHHHHHHH
34.8828857561
237UbiquitinationLGKRRELKAAVPDTV
HHHHHHHHHHCCCCC
29.55-
256PhosphorylationLKAALKLYHVSDSEG
HHHHHHHHEEECCCC
9.8912269817
259PhosphorylationALKLYHVSDSEGNLV
HHHHHEEECCCCCEE
23.3123312004
261PhosphorylationKLYHVSDSEGNLVVR
HHHEEECCCCCEEEE
39.6423312004
286PhosphorylationLLSHEDCYILDQGGL
HHCCCCEEEEECCCE
19.4816921170
324PhosphorylationNFIKAKQYPPSTQVE
HHHHHCCCCCCCEEE
19.1916921170
350PhosphorylationQQLFQKWTASNRTSG
HHHHHHHHHCCCCCC
27.5223312004
352PhosphorylationLFQKWTASNRTSGLG
HHHHHHHCCCCCCCC
21.3323312004
355PhosphorylationKWTASNRTSGLGKTH
HHHHCCCCCCCCCCC
31.2523312004
356PhosphorylationWTASNRTSGLGKTHT
HHHCCCCCCCCCCCC
28.8723312004
363PhosphorylationSGLGKTHTVGSVAKV
CCCCCCCCCCCEEEE
31.6226657352
366PhosphorylationGKTHTVGSVAKVEQV
CCCCCCCCEEEEEEE
17.9929802988
378PhosphorylationEQVKFDATSMHVKPQ
EEEEECCEECCCCHH
28.5528857561
379PhosphorylationQVKFDATSMHVKPQV
EEEECCEECCCCHHH
14.4928857561
415PhosphorylationLELVPVDSKWLGHFY
CEEEECCCCCCCHHC
26.4326471730
461PhosphorylationDEITASAYQAVILDQ
HHHHHHHHHEEEECC
8.4316921170
490PhosphorylationKEPPHLMSIFKGRMV
CCCCCHHEEECCCEE
31.1024719451
514PhosphorylationNNLETGPSTRLFQVQ
CCCCCCCCEEEEEEE
27.7528857561
515PhosphorylationNLETGPSTRLFQVQG
CCCCCCCEEEEEEEC
34.2328857561
529UbiquitinationGTGANNTKAFEVPAR
CCCCCCCEEEECCCC
53.88-
552PhosphorylationVFVLKTQSCCYLWCG
EEEEEECCEEEEECC
16.0428857561
555PhosphorylationLKTQSCCYLWCGKGC
EEECCEEEEECCCCC
13.9416921170
604PhosphorylationALGGKAPYANTKRLQ
HHCCCCCCCCCCHHH
19.8316921170
618PhosphorylationQEENLVITPRLFECS
HHCCEEECCCEEECC
8.5523312004
681PhosphorylationAATTAQEYLKTHPSG
HHHHHHHHHHHCCCC
11.0421712546
693PhosphorylationPSGRDPETPIIVVKQ
CCCCCCCCCEEEEEC
25.7723312004
720PhosphorylationAWDPFKWSNTKSYED
EECCCCCCCCCCHHH
34.9028857561
722PhosphorylationDPFKWSNTKSYEDLK
CCCCCCCCCCHHHHH
18.8228857561
724PhosphorylationFKWSNTKSYEDLKAE
CCCCCCCCHHHHHHH
31.5428857561
725PhosphorylationKWSNTKSYEDLKAEL
CCCCCCCHHHHHHHH
18.2816921170
729AcetylationTKSYEDLKAELGNSR
CCCHHHHHHHHCCCC
52.737365989
735PhosphorylationLKAELGNSRDWSQIT
HHHHHCCCCCHHHHE
29.8029414761
739PhosphorylationLGNSRDWSQITAEVT
HCCCCCHHHHEEEEC
18.9228857561
746PhosphorylationSQITAEVTSPKVDVF
HHHEEEECCCCEEEE
30.7129414761
747PhosphorylationQITAEVTSPKVDVFN
HHEEEECCCCEEEEE
28.0928188228
810PhosphorylationGMTPAAFSALPRWKQ
CCCHHHHHHCHHHHH
24.9524719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
46YPhosphorylationKinaseSRCP12931
PSP
60YPhosphorylationKinaseSRCP12931
PSP
64YPhosphorylationKinaseSRCP12931
PSP
81YPhosphorylationKinaseSRCP12931
PSP
256YPhosphorylationKinaseSRCP12931
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of VILI_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of VILI_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TEX11_HUMANTEX11physical
16189514
RAE1_HUMANCHMphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of VILI_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP